Brief: Lixte Biotechnology Raises $4.3M in Market‑Priced Registered Direct Offering
Dec 18 (Reuters) - Lixte Biotechnology Holdings Inc LIXT.O: LIXTE BIOTECHNOLOGY HOLDINGS, INC. ANNOUNCES $4.3 MILLION REGISTERED DIRECT OFFERING PRICED AT THE MARKET UNDER NASDAQ RULES Source text: ID:nGNX9ygsk9 Further company coverage: LIXT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on NOMAD Power Solutions
See all newsBrief: Nomad Power Solutions Files 2026 Second Quarter Form 10-Q, Provides Business Update
U.S. STOCKS ON THE MOVE-SpaceX, Tesla, Woodside Energy Group
U.S. STOCKS ON THE MOVE-SpaceX, SharonAI, Medline
U.S. STOCKS ON THE MOVE-SpaceX, SharonAI, Medline
LIXTE to buy battery firm NOMAD, shifts away from cancer drugs; shares rise